Medical Management of Caries in the Primary Dentition Using Silver Nitrate

Sponsor
Arwa Owais (Other)
Overall Status
Completed
CT.gov ID
NCT02604134
Collaborator
Delta Dental of Iowa (Other)
122
1
2
49.7
2.5

Study Details

Study Description

Brief Summary

This pilot trial compares conventional restorations with a new strategy based on the medical management of caries using silver nitrate and fluoride varnish with no restorations.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Prophylaxis
  • Drug: Fluoride varnish
  • Drug: Silver Nitrate
Early Phase 1

Detailed Description

This is a two-arm, parallel group, patient-randomized controlled pilot trial. Children with at least one primary tooth where caries extends into dentine. Children will be randomized and treated according to one of two treatment approaches;(1) conventional caries management with best practice prevention, or (2) medical management of caries using silver nitrate with best practice prevention.

Baseline measures and outcome data (at treatment/review during two year follow-up) are assessed through direct reporting, clinical examination including blinded radiographic assessment, and child/parent questionnaires.

Study Design

Study Type:
Interventional
Actual Enrollment :
122 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Masking Description:
the radiographic progression of caries is assessed by a masked investigator
Primary Purpose:
Treatment
Official Title:
Medical Management of Caries in the Primary Dentition Using Silver Nitrate: A Pilot Study
Study Start Date :
Jul 1, 2014
Actual Primary Completion Date :
Aug 24, 2017
Actual Study Completion Date :
Aug 21, 2018

Arms and Interventions

Arm Intervention/Treatment
Other: conventional treatment group

The child will receive a prophylaxis and fluoride varnish. Parents will fill out a parent and a child questionnaire.

Procedure: Prophylaxis
A dental prophylaxis is a cleaning procedure performed to thoroughly clean the teeth. Prophylaxis is an important dental treatment for halting the progression of periodontal disease and gingivitis.
Other Names:
  • Prophy
  • Drug: Fluoride varnish
    Fluoride varnish is a highly concentrated form of fluoride which is applied to the tooth's surface, by a dentist, dental hygienist or other health care professional, as a type of topical fluoride therapy.
    Other Names:
  • Fluoride
  • Other: Silver Nitrate group

    The child will receive a prophylaxis, then silver nitrate and then fluoride varnish. Parents will fill out a parent and a child questionnaire.

    Procedure: Prophylaxis
    A dental prophylaxis is a cleaning procedure performed to thoroughly clean the teeth. Prophylaxis is an important dental treatment for halting the progression of periodontal disease and gingivitis.
    Other Names:
  • Prophy
  • Drug: Fluoride varnish
    Fluoride varnish is a highly concentrated form of fluoride which is applied to the tooth's surface, by a dentist, dental hygienist or other health care professional, as a type of topical fluoride therapy.
    Other Names:
  • Fluoride
  • Drug: Silver Nitrate
    a small amount will be applied to the tooth via a cotton applicator. Silver nitrate is a colorless, odorless, transparent solution used as an escharotic, dehydrating and sclerosing agent.

    Outcome Measures

    Primary Outcome Measures

    1. Change in baseline Caries Experience and activity (Incidence of caries in primary teeth) [through study completion, for 2 years]

      Detailed measurements of caries experience will be recorded at baseline and annual caries examination using EC4

    Secondary Outcome Measures

    1. Caries activity in primary teeth [through study completion, for 2 years]

      Detailed measurements of caries activity will be recorded at baseline and annual caries examination using Nyvad scores.

    Other Outcome Measures

    1. Pain (toothache) and/or infection in primary teeth [through study completion, for 2 years]

      Assessments for pain from toothache will be made at each visit throughout the patient's participation in the trial using the Dental Discomfort Questionnaire completed by the parents.

    2. Patient quality of life [through study completion, for 2 years]

      Quality of life will be assessed through direct reporting by parents and children about pain and related activities

    3. Cost-effectiveness [through study completion, for 2 years]

      Cost-effectiveness for both groups will be calculated and compared

    4. Acceptability of treatment strategies by parents and children [through study completion, for 2 years]

      Acceptability is checked throughout the whole period of the study every time the patient comes in for a recall

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    2 Years to 11 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Presense of one or more cavitated carious lesions in the primary dentition, extending into dentin but not encroaching on the pulp.

    • Absense of any spontaneous or elicited pain due to caries, or signs of pulpal infection in response to any of the carious lesions in the primary dentition to be included in the study

    Exclusion Criteria:
    • Hereditary developmental defects of the teeth such as Amelogenesis Imperfecta and Dentinogenesis Imperfecta

    • Medical conditions that prevent treatment of the child in the outpatient clinic. These conditions include severe bleeding disorders, cardiac problems and mental disabilities that prevent child from communication with the research team.

    • Known allergy/sensitivity to any of the dental materials.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 UIowa Iowa City Iowa United States 52242

    Sponsors and Collaborators

    • Arwa Owais
    • Delta Dental of Iowa

    Investigators

    • Principal Investigator: Arwa I Owais, BDS, MS, Associate Profesor in Pediatric Dentistry
    • Principal Investigator: MIchael Kanellis, DDS, MS, Professor in Pediatric Dentistry & Dean for Patient Cares

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Arwa Owais, Principal Investigator, University of Iowa
    ClinicalTrials.gov Identifier:
    NCT02604134
    Other Study ID Numbers:
    • 201406792
    First Posted:
    Nov 13, 2015
    Last Update Posted:
    Jul 11, 2019
    Last Verified:
    Jul 1, 2019
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    Yes
    Studies a U.S. FDA-regulated Device Product:
    No
    Product Manufactured in and Exported from the U.S.:
    No
    Keywords provided by Arwa Owais, Principal Investigator, University of Iowa
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jul 11, 2019